Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - Nexentis Technologies Inc. (0001789192) (Issuer)
3 - Nexentis Technologies Inc. (0001789192) (Issuer)
Visit Nexentis at: www.nexentistech.com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ:NXTS), ("Nexentis" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, is proud to announce the launch of its new corporate website at www.nexentistech.com. This digital milestone follows the company's recent rebranding from N2OFF, Inc., and underscores its commitment to advancing mitochondrial biology for breakthroughs in precision oncology and inflammatory metabolic diseases. The newly launched website serves as a comprehensive hub for stakeholders, including investors,
S-3 - Nexentis Technologies Inc. (0001789192) (Filer)
8-K - Nexentis Technologies Inc. (0001789192) (Filer)
10-K - Nexentis Technologies Inc. (0001789192) (Filer)